CareDx owes Natera $96 mln in genetic-testing patent case, US jury says [Reuters]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Reuters
damages after finding that rival CareDx's (CDNA.O) , opens new tab AlloSure and AlloSeq kidney-transplant tests infringe a Natera patent, according to a verdict made public on Monday. The jury determined , opens new tab that Natera was entitled to more than $83.6 million in lost profits and $12.6 million in royalties from CareDx. The Friday verdict came after the same jury concluded earlier in the day that CareDx had infringed one of Natera's two patents at issue in the case. CareDx said in a court filing that Natera had sought more than $149 million in lost-profit damages. Austin, Texas-based Natera said in a statement on Monday that it was pleased with the verdict. CareDx said earlier that it plans to appeal and that the verdict would not affect the availability of the company's tests. Natera had accused CareDx of infringing patents related to the use of cell-free DNA to assess the risk that a person's body will reject a kidney transplant. Brisbane, California-based CareDx
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx to Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- CareDx to Report First Quarter 2024 Financial ResultsBusiness Wire
- Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)Business Wire
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- 4/25/24 - Form S-8
- CDNA's page on the SEC website